Predictors of Insulin Initiation in Patients with Type 2 Diabetes: An Analysis of the Look AHEAD Randomized Trial
- 1 June 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of General Internal Medicine
- Vol. 33 (6), 839-846
- https://doi.org/10.1007/s11606-017-4282-9
Abstract
The decision to initiate insulin in patients with type 2 diabetes is a challenging escalation of care that requires an individualized approach. However, the sociodemographic and clinical factors affecting insulin initiation are not well understood. We sought to identify patient factors that were independent predictors of insulin initiation among participants in the Look AHEAD (Action for Health in Diabetes) clinical trial. Retrospective analysis of a randomized clinical trial. Beginning in 2001, Look AHEAD enrolled ambulatory U.S. adults with type 2 diabetes who were overweight or obese and had a primary healthcare provider. Participants were randomized (1:1) to an intensive lifestyle intervention, or diabetes support and education. This study examined 3913 participants across the two trial arms who were not using insulin at baseline. We used Cox proportional hazards models to estimate the association between participant characteristics and time to insulin initiation. We performed time-varying adjustment for HbA1c measured eight times over the 10-year study period, as well as for multiple clinical and socioeconomic factors. A total of 1087 participants (27.8%) initiated insulin during a median follow-up of 8.0 years. Age was inversely associated with insulin initiation (adjusted hazard ratio [aHR] 0.88 per 10 years, P = 0.025). The risk of insulin initiation was greater with a higher number of diabetes complications (P < 0.001 for trend); chronic kidney disease and cardiovascular disease were independently associated with insulin initiation. There was a lower risk of insulin initiation in black (aHR 0.77, P = 0.008) and Hispanic participants (aHR 0.66, P < 0.001) relative to white participants. Socioeconomic factors were not associated with insulin initiation. Patient age, race/ethnicity, and diabetes complications may influence insulin initiation in type 2 diabetes, independent of glycemic control. Future work is needed to understand the drivers of racial differences in antihyperglycemic treatment, and to identify patients who benefit most from insulin.Keywords
This publication has 30 references indexed in Scilit:
- Racial/Ethnic- and Education-Related Disparities in the Control of Risk Factors for Cardiovascular Disease Among Individuals With DiabetesDiabetes Care, 2012
- The development and description of the comparison group in the Look AHEAD trialClinical Trials, 2011
- Long-term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals With Type 2 Diabetes MellitusArchives of Internal Medicine, 2010
- Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetesDiabetes & Metabolism, 2010
- Primary care physician beliefs about insulin initiation in patients with type 2 diabetesInternational Journal of Clinical Practice, 2008
- Disparities in A1C Levels Between Hispanic and Non-Hispanic White Adults With DiabetesDiabetes Care, 2008
- Delay Of Insulin Addition To Oral Combination Therapy Despite Inadequate Glycemic ControlJournal of General Internal Medicine, 2007
- Disparities in HbA1c Levels Between African-American and Non-Hispanic White Adults With DiabetesDiabetes Care, 2006
- Understanding Diabetes Medications From the Perspective of Patients With Type 2 DiabetesThe Diabetes Educator, 2006
- The Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting ItObesity, 2006